Tim Kaine actually said...

the issue is, is it the pharmaceutical manufacturers? Is it the pharmacy benefit manufacturers?

We neglected the need for accountability.

the net price of insulin has actually decreased, even as the list price has increased

the ability to afford the insulin is equally important as to the innovation that may have occurred